Optimizing the use of Aquacel Ag® for pediatric burns - When to start?

D Kruchevsky1, Y Pikkel1, S Mattar1

  • 1Department of Plastic and Reconstructive Surgery, Rambam Health Care Campus, Haifa, Israel.

Insights

Aquacel Ag® dressings reduce changes for pediatric partial thickness burns. Optimal use involves applying on day 1 post-burn for superficial burns, or day 2 for deep burns, improving cost-effectiveness.

Area of Science:

  • Pediatric Burn Care
  • Wound Management Technologies
  • Dermatology

Background:

  • Pediatric partial thickness burns often heal with supportive care, but standardized protocols are lacking.
  • Aquacel Ag® dressings show promise in reducing dressing change frequency for pediatric burns.
  • Optimizing Aquacel Ag® use requires understanding its application timing and burn depth impact.

Purpose of the Study:

  • To review institutional experience with Aquacel Ag® for pediatric partial thickness burns.
  • To optimize the use and cost-effectiveness of Aquacel Ag® dressings.
  • To determine the ideal timing and conditions for Aquacel Ag® application in pediatric burn management.

Main Methods:

  • Retrospective study of pediatric burn patients (July 2013 - May 2018).
  • Analysis of 705 dressing changes across 276 patients, focusing on Aquacel Ag® use (48% of cases).
  • Examination of dressing change intervals based on application day and burn depth.

Main Results:

  • Aquacel Ag® applied on day 1 post-burn had significantly longer change intervals (4.85 days) vs. day of injury (2.21 days).
  • For superficial 2nd-degree burns, application on day 1 post-burn led to less frequent changes (4.95 days) compared to deep 2nd-degree burns (2.29 days).
  • Aquacel Ag® use was most prevalent, indicating its significant role in the study cohort.

Conclusions:

  • Initiate Aquacel Ag® dressing on day 1 post-burn for superficial partial thickness burns.
  • Consider Aquacel Ag® application on day 2 for suspected deep partial thickness burns.
  • Standard topical preparations are recommended until Aquacel Ag® is optimally applied to enhance cost-effectiveness and reduce changes.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
3.8K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
393
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
168
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
164